Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

103.09 -0.79 (-0.76%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,285,660
Open 102.75
Bid (Size) 101.58 (100)
Ask (Size) 106.00 (100)
Prev. Close 103.88
Today's Range 101.52 - 105.00
52wk Range 81.20 - 129.27
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run ↗
Pfizer plans to sell its remaining BioNTech stake through a $508 million block trade, ending a profitable Covid-19 vaccine partnership. 
Via Benzinga
News headline image
BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company ↗
A BioNTech spokesperson told Reuters that the two companies continue to have a “close and strong collaboration.” 
Via Stocktwits

Performance

YTD
-10.6%
-10.6%
1 Month
+0.5%
+0.5%
3 Month
-8.5%
-8.5%
6 Month
+11.6%
+11.6%
1 Year
-7.5%
-7.5%

More News

Read More
News headline image
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership ↗
Via Benzinga
News headline image
BioNTech SE (NASDAQ:BNTX) Reports Mixed Q3 2025 Results with Major Revenue Beat and Quarterly Loss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 3, 2025 ↗
Via Benzinga
News headline image
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
News headline image
BioNTech to Host Innovation Series R&D Day on November 11, 2025
From BioNTech SE
Via GlobeNewswire
News headline image
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
From BioNTech SE
Via GlobeNewswire
News headline image
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever ↗
Via The Motley Fool
Topics Government Intellectual Property World Trade
News headline image
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
From BioNTech SE
Via GlobeNewswire
News headline image
Beyond The Numbers: 7 Analysts Discuss BioNTech Stock ↗
Via Benzinga
News headline image
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
Via MarketMinute
News headline image
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗
Via The Motley Fool
Topics Government World Trade
News headline image
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
Via MarketMinute
Topics Artificial Intelligence Derivatives
News headline image
Why BioNTech Stock Jumped by Nearly 4% on Wednesday ↗
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
News headline image
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
From BioNTech SE
Via GlobeNewswire
News headline image
Why BioNTech Stock Bumped Higher Today ↗
Via The Motley Fool
News headline image
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids ↗
Via Investor's Business Daily
News headline image
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut ↗
Via Investor's Business Daily
Topics Government
News headline image
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax ↗
Via Benzinga
News headline image
Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks ↗
Via Chartmill
Topics Artificial Intelligence Economy
News headline image
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio? ↗
Via Benzinga
Topics Earnings

Frequently Asked Questions

Is BioNTech SE - American Depositary Shares publicly traded?
Yes, BioNTech SE - American Depositary Shares is publicly traded.
What exchange does BioNTech SE - American Depositary Shares trade on?
BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BioNTech SE - American Depositary Shares?
The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
What is the current price of BioNTech SE - American Depositary Shares?
The current price of BioNTech SE - American Depositary Shares is 103.09
When was BioNTech SE - American Depositary Shares last traded?
The last trade of BioNTech SE - American Depositary Shares was at 11/14/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.